The decrease in RQ was, however, similar between the HFS mice that received AAV-shRNA-Scramble and those treated with AAV-shRNA-Cx43, suggesting that the reduction in Cx43 expression does not alter the propensity to develop signs of metabolic syndrome. The gene discussed is GJA1; the disease is metabolic syndrome.